{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:01:32Z","timestamp":1764784892235,"version":"3.37.3"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CORPG3K0301"],"award-info":[{"award-number":["CORPG3K0301"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijid.2022.06.044","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T07:23:54Z","timestamp":1656660234000},"page":"537-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Changes in interferon-\u03b3 release assay readout after COVID-19 vaccination: A prospective cohort study"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8922-397X","authenticated-orcid":false,"given":"Nan-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo-Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wei","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang-Shen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ing-Kit","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Yuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ssu-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hsiang","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Shu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.06.044_bib0001","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41591-020-01179-4","article-title":"Oxford COVID Vaccine Trial Group. Phase 1\/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses","volume":"27","author":"Barrett","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2022.06.044_bib0003","unstructured":"Chorba T. TB tests and mRNA COVID-19 vaccines. Available at: https:\/\/www.cdc.gov\/tb\/publications\/letters\/covid19-mrna.html, 2021. Accessed December 23, 2021."},{"key":"10.1016\/j.ijid.2022.06.044_bib0004","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.vaccine.2021.02.007","article-title":"A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine","volume":"39","author":"Chu","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2022.06.044_bib0005","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2022.06.044_bib0006","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1473-3099(17)30402-4","article-title":"Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study","volume":"17","author":"Gao","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.044_bib0007","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1532-5415.2011.03367.x","article-title":"Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home","volume":"59","author":"Katsenos","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ijid.2022.06.044_bib0008","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and Type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2022.06.044_bib0009","first-page":"719","article-title":"Diabetes mellitus and latent tuberculosis infection: A systematic review and metaanalysis","volume":"64","author":"Lee","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.044_bib0010","doi-asserted-by":"crossref","first-page":"30781","DOI":"10.1038\/srep30781","article-title":"Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model","volume":"6","author":"Moses","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2022.06.044_bib0011","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomized, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.06.044_bib0012","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/cid\/ciu139","article-title":"False-positive QuantiFERON results at a large healthcare institution","volume":"58","author":"Slater","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.044_bib0013","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/rccm.201305-0831OC","article-title":"Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers","volume":"188","author":"Slater","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2022.06.044_bib0014","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/med.21756","article-title":"SARS-CoV-2-mediated immune system activation and potential application in immunotherapy","volume":"41","author":"Tan","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ijid.2022.06.044_bib0015","unstructured":"World Health Organization (WHO), Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260233\/9789241550239-eng.pdf, 2018. Accessed December 23, 2021."},{"key":"10.1016\/j.ijid.2022.06.044_bib0002","unstructured":"Centers for Disease Control and Prevention (CDC) US, Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. Available at: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fclinical-considerations.html, 2021. Accessed November 5, 2021."},{"key":"10.1016\/j.ijid.2022.06.044_bib0017","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1081\/JDI-48243","article-title":"Clinical comparisons of 1,498 chronic renal failure patients with and without tuberculosis","volume":"27","author":"Yuan","year":"2005","journal-title":"Ren Fail"},{"key":"10.1016\/j.ijid.2022.06.044_bib0016","unstructured":"World Health Organization. Tuberculosis. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis, 2021. Accessed December 23, 2021."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222003824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222003824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T14:34:23Z","timestamp":1715438063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222003824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":17,"alternative-id":["S1201971222003824"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.06.044","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in interferon-\u03b3 release assay readout after COVID-19 vaccination: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}